Tag: remibrutinib
Chronic Spontaneous Urticaria: Second-Line Treatments You Need to Know
Second-line treatments for chronic spontaneous urticaria like omalizumab, remibrutinib, and dupilumab offer real hope for patients who don't respond to antihistamines. Learn how they work, who they help, and what's coming next.
Read More- December 20, 2025
- Neil Hirsch
- 0 Comments